-transparent.png){kind=logo}
The diagnosis and management of ovarian hemorrhage complicating anticoagulant therapy is discussed and a case presented. The patient, who had undergone mitral valve replacement and was receiving chronic anticoagulation treatment, was admitted with signs of intraperitoneal bleeding from a ruptured ovarian hematoma. This complication must be considered in the menstruating female who is receiving anticoagulant therapy. Long-term anovulatory therapy could possibly avoid this potential ovarian hemorrhage.
Related Publications
J Itskovitz, and
J M Brandes, and
J Urbach, and
M Fisher
January 1977,
Mayo Clinic proceedings,
J Itskovitz, and
J M Brandes, and
J Urbach, and
M Fisher
July 2005,
Nihon Hinyokika Gakkai zasshi. The japanese journal of urology,
J Itskovitz, and
J M Brandes, and
J Urbach, and
M Fisher
March 1987,
Israel journal of medical sciences,
J Itskovitz, and
J M Brandes, and
J Urbach, and
M Fisher
April 1973,
Obstetrics and gynecology,
J Itskovitz, and
J M Brandes, and
J Urbach, and
M Fisher
July 1994,
Revista espanola de enfermedades digestivas,
J Itskovitz, and
J M Brandes, and
J Urbach, and
M Fisher
January 2012,
Breast disease,
J Itskovitz, and
J M Brandes, and
J Urbach, and
M Fisher
January 2006,
Medical principles and practice : international journal of the Kuwait University, Health Science Centre,
J Itskovitz, and
J M Brandes, and
J Urbach, and
M Fisher
April 1976,
American journal of obstetrics and gynecology,
J Itskovitz, and
J M Brandes, and
J Urbach, and
M Fisher
October 1965,
Mayo Clinic proceedings,
J Itskovitz, and
J M Brandes, and
J Urbach, and
M Fisher
January 1998,
Journal de radiologie,
